- Home
- RNXT vs CXAI Comparison
RNXT vs CXAI Comparison
Compare RNXT & CXAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNXT
- CXAI
- Stock Information
- Founded
- RNXT 2012
- CXAI N/A
- Country
- RNXT United States
- CXAI United States
- Employees
- RNXT N/A
- CXAI N/A
- Industry
- RNXT Biotechnology: Pharmaceutical Preparations
- CXAI EDP Services
- Sector
- RNXT Health Care
- CXAI Technology
- Exchange
- RNXT Nasdaq
- CXAI Nasdaq
- Market Cap
- RNXT 44.6M
- CXAI 16.0M
- IPO Year
- RNXT 2021
- CXAI N/A
- Fundamental
- Price
- RNXT $1.27
- CXAI $0.73
- Analyst Decision
- RNXT Strong Buy
- CXAI
- Analyst Count
- RNXT 2
- CXAI 0
- Target Price
- RNXT $7.50
- CXAI N/A
- AVG Volume (30 Days)
- RNXT 579.5K
- CXAI 647.0K
- Earning Date
- RNXT 11-12-2025
- CXAI 11-11-2025
- Dividend Yield
- RNXT N/A
- CXAI N/A
- EPS Growth
- RNXT N/A
- CXAI N/A
- EPS
- RNXT N/A
- CXAI N/A
- Revenue
- RNXT $662,000.00
- CXAI $6,005,000.00
- Revenue This Year
- RNXT $2,988.37
- CXAI N/A
- Revenue Next Year
- RNXT $300.60
- CXAI $60.00
- P/E Ratio
- RNXT N/A
- CXAI N/A
- Revenue Growth
- RNXT N/A
- CXAI N/A
- 52 Week Low
- RNXT $0.75
- CXAI $0.61
- 52 Week High
- RNXT $1.69
- CXAI $2.54
- Technical
- Relative Strength Index (RSI)
- RNXT 60.58
- CXAI 42.64
- Support Level
- RNXT $1.06
- CXAI $0.66
- Resistance Level
- RNXT $1.45
- CXAI $0.79
- Average True Range (ATR)
- RNXT 0.11
- CXAI 0.05
- MACD
- RNXT 0.03
- CXAI 0.01
- Stochastic Oscillator
- RNXT 67.27
- CXAI 55.54
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
About CXAI CXApp Inc.
CXApp Inc is a provider of AI-powered employee experience solutions, delivering enterprise-grade software that enhances workplace engagement, productivity, and operational efficiency. The company's flagship product, the CXAI Platform, provides a comprehensive suite of tools designed to empower employees and enable organizations to create smarter workplaces. The product's key components include CXAI Apps, CXAI BTS, and CXAI-VU. The company generates the majority of its revenue from Licenses.